​

Cadrenal Therapeutics Ownership | Who Owns Cadrenal Therapeutics?


OverviewFinancialsChart

Cadrenal Therapeutics Ownership Summary


Cadrenal Therapeutics is owned by 3.86% institutional investors, 11.93% insiders, and 84.21% retail investors. Vectors research management is the largest institutional shareholder, holding 0.68% of CVKD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.42% of its assets in Cadrenal Therapeutics shares.

CVKD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCadrenal Therapeutics3.86%11.93%84.21%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vectors research management19.84K0.68%$21.42K
Geode capital management18.96K0.65%$20.47K
Jane street group13.72K0.47%$14.82K
Squarepoint ops12.36K0.42%$13.35K
Vanguard fiduciary trust8.31K0.35%$42.55K
Nuveen7.24K0.25%$7.89K
Ubs group5.86K0.20%$6.33K
Barclays3.89K0.13%$4.20K
Tower research capital llc (trc)393.000.02%$2.01K
Quest 10 wealth builders380.000.01%$410.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Vectors research management19.84K0.01%$21.42K
Quest 10 wealth builders380.000.00%$410.00
Tower research capital llc (trc)393.000.00%$2.01K
Drw securities---
Ifp advisors30.00-$154.00
Barclays3.89K-$4.20K
Harbour investments---
Jane street group13.72K-$14.82K
Advisor group300.00-$324.00
Destiny wealth partners---

Top Buyers

HolderShares% AssetsChange
Vectors research management19.84K0.01%19.84K
Jane street group13.72K-13.72K
Squarepoint ops12.36K-12.36K
Vanguard fiduciary trust8.31K-8.31K
Nuveen7.24K-7.24K

Top Sellers

HolderShares% AssetsChange
Drw securities---25.15K
Lpl financial---13.00K
Jpmorgan chase---7.50K
Blackrock funding, inc. /de---5.50K
Morgan stanley100.00--980.00

New Positions

HolderShares% AssetsChangeValue
Vectors research management19.84K0.01%19.84K$21.42K
Jane street group13.72K-13.72K$14.82K
Squarepoint ops12.36K-12.36K$13.35K
Vanguard fiduciary trust8.31K-8.31K$42.55K
Nuveen7.24K-7.24K$7.89K

Sold Out

HolderChange
Curio wealth-1.00
Citigroup-1.00
Harbour investments-100.00
Destiny wealth partners-200.00
Clearstead advisors-650.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202617-112,45023.66%327.06%1042.86%1-80.00%
Mar 31, 202617-5.56%90,938-25.15%310.17%7-5150.00%
Dec 31, 2025185.88%121,4866.39%619.52%7-12.50%2-33.33%
Sep 30, 20251721.43%114,19367.08%546.02%814.29%3-
Jun 30, 2025147.69%68,347-1.38%324.67%7-36.36%3200.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv33.28K1.42%-
Vanguard Morn Total Stk Mkt Idx Investor33.28K1.07%-
Vanguard MStar Total Stk Mkt Idx Invest33.28K0.93%-
Vanguard Institutional Extnd Mkt Idx Tr16.86K0.54%-
Abante Quant Value FI12.95K0.36%-
Fidelity Extended Market Index12.24K0.34%-
iShares Micro-Cap ETF5.23K0.17%-
Spartan Extended Market Index Pool F2.30K0.10%-
Fidelity Series Total Market Index2.45K0.07%-
NT Ext Equity Mkt Index Fund - NL1.55K0.07%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 29, 2026Pham Quang X Chairman and CEOSell$22.42K
Jun 26, 2026Pham Quang X Chairman, CEO and Interim CFOSell$27.54K
Jun 25, 2026Pham Quang X Chairman, CEO and Interim CFOSell$6.38K
Jun 22, 2026Pham Quang X Chairman, CEO and Interim CFOSell$32.54K
Jun 23, 2026Pham Quang X Chairman, CEO and Interim CFOSell$7.29K

Insider Transactions Trends


DateBuySell
2026 Q2-21
2025 Q4-13
2025 Q3-10
2025 Q1--
2024 Q2--

CVKD Ownership FAQ


Who Owns Cadrenal Therapeutics?

Cadrenal Therapeutics shareholders are primarily institutional investors at 3.86%, followed by 11.93% insiders and 84.21% retail investors. The average institutional ownership in Cadrenal Therapeutics's industry, Biotech Stocks , is 385.89%, which Cadrenal Therapeutics falls below.

Who owns the most shares of Cadrenal Therapeutics?

Cadrenal Therapeutics’s largest shareholders are Vectors research management (19.84K shares, 0.68%), Geode capital management (18.96K shares, 0.65%), and Jane street group (13.72K shares, 0.47%). Together, they hold 1.80% of Cadrenal Therapeutics’s total shares outstanding.

Does Blackrock own Cadrenal Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cadrenal Therapeutics.

Who is Cadrenal Therapeutics’s biggest shareholder by percentage of total assets invested?

Vectors research management is Cadrenal Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 19.84K Cadrenal Therapeutics shares, valued at 21.42K$.

Who is the top mutual fund holder of Cadrenal Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cadrenal Therapeutics shares, with 1.42% of its total shares outstanding invested in 33.28K Cadrenal Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools